Back to search
🇺🇸

United States · US · US:62332-223_0f406336-e614-4427-89c7-bd26d3792590

DARIFENACIN

Orange BookUNIISPLATC G04BD10

Last synced from FDA National Drug Code directory (United States) on

Identification

ManufacturerAlembic Pharmaceuticals Inc.
CountryUS (United States)
ATC codeG04BD10
Dispensing
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026

Packs · 4

  • ndc11
    6233222308
    8 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (62332-223-08)
  • ndc11
    6233222330
    30 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-223-30)
  • ndc11
    6233222390
    90 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-223-90)
  • ndc11
    6233222391
    1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-223-91)

Annotations

UNII (FDA Substance ID)
CR02EYQ8GV
DARIFENACIN HYDROBROMIDE
RxCUI 485417
Orange Book
A207681
ABAB
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
  "unii": {
    "unii": "CR02EYQ8GV",
    "rxcui": "485417",
    "inchikey": "UQAVIASOPREUIT-VQIWEWKSSA-N",
    "display_name": "DARIFENACIN HYDROBROMIDE",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "ORAL",
  "spl_meta": {
    "e84f1ae3-b9a2-4a15-a299-c75373891cc1": {
      "match": "brand_token",
      "title": "DARIFENACIN TABLET, EXTENDED RELEASE [TORRENT PHARMACEUTICALS LIMITED]",
      "spl_version": "10",
      "published_date": "2026-03-03"
    }
  },
  "productid": "62332-223_0f406336-e614-4427-89c7-bd26d3792590",
  "productndc": "62332-223",
  "dosage_form": "TABLET, EXTENDED RELEASE",
  "orange_book": {
    "appl_no": "207681",
    "products": [
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "EQ 7.5MG BASE",
        "product_no": "001",
        "approval_date": "Dec 8, 2017"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "EQ 15MG BASE",
        "product_no": "002",
        "approval_date": "Dec 8, 2017"
      }
    ],
    "appl_type": "A"
  },
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "DARIFENACIN HYDROBROMIDE",
  "proprietary_name": "DARIFENACIN",
  "active_ingred_unit": "mg/1",
  "application_number": "ANDA207681",
  "marketing_category": "ANDA",
  "nonproprietary_name": "DARIFENACIN",
  "start_marketing_date": "20171212",
  "active_numerator_strength": "7.5"
}

Related drugs

Other records sharing ATC code G04BD10.

Access this data programmatically

Query DARIFENACIN and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.